NCT04559568View on ClinicalTrials.gov

A Study of LY3522348 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

October 15, 2020

Primary Completion Date

August 17, 2021

Study Completion Date

August 17, 2021

Conditions
Healthy
Interventions
DRUG

LY3522348

Administered orally.

DRUG

Placebo

Administered orally.

DRUG

Midazolam

Administered orally to some participants.

Trial Locations (1)

32117

Covance Clinical Research Inc, Daytona Beach

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT04559568 - A Study of LY3522348 in Healthy Participants | Biotech Hunter | Biotech Hunter